Haemangiosarcoma: The Hard Truth About the "Silent" Splenic Cancer

Haemangiosarcoma, often shortened to HSA, is a cancer of the cells that line blood vessels (Cornell University, 2024). Because blood vessels run everywhere, it can crop up almost anywhere, but it has favourite places. The commonest by far is the spleen, an organ tucked up near the stomach whose job involves storing and filtering blood. After that come the right side of the heart, the liver, and the skin (Cornell University, 2024).

That blood-vessel origin matters, and it explains nearly everything about how this cancer behaves. A tumour made of malformed blood vessels is, in effect, a fragile bag of blood. It can grow quietly for weeks or months, then tear, and when it tears it bleeds. That single fact is why splenic haemangiosarcoma earns its grim nickname, the silent killer, and why it catches so many families completely off guard (AKC, 2023).

It turns up most in older, larger dogs, usually somewhere between about eight and twelve years old, and a few breeds are over-represented, among them German Shepherds, Golden Retrievers, Labradors, Boxers and Portuguese Water Dogs (Cornell University, 2024; AKC, 2023). If you own one of those breeds, please don't read that as a sentence. Most German Shepherds never get this. It simply means it's a name worth knowing.

This is the part that owners find hardest to make sense of afterwards. How could a dog who seemed completely well that morning be fighting for his life by the afternoon? It feels like it came from nowhere. It didn't, and understanding why can take a little of the guilt away, because there was almost certainly nothing you missed.

For most of its life, a splenic tumour causes no trouble you could possibly spot. It sits there, deep inside the belly where you can't feel it, growing slowly, while your dog eats, walks and plays as normal (Cornell University, 2024). Some dogs have nothing more than the odd off day, a bit of tiredness, slightly less interest in dinner, the sort of thing any older dog has and nobody would think twice about (Cornell University, 2024). There's no lump to find, no limp, no obvious sign. The cancer is genuinely hidden.

The crisis comes when the tumour bleeds. A blood-filled growth eventually develops a weak spot and tears, and blood leaks out into the abdomen (Cornell University, 2024). A small bleed can cause a brief wobble that seems to pass, which is why some dogs have a mysterious "funny turn" a week or two before the big one. A large bleed is a true emergency. The dog loses a lot of blood very fast into his own belly, and that's what causes the sudden collapse.

So it isn't that the cancer appeared overnight. It's that the bleed did. The cancer was there all along, quietly, and a quiet cancer is exactly the kind you can't catch early by watching. This is not a failure of attention on your part.

If this is happening right now: a dog with a sudden collapse, pale or white gums, fast or laboured breathing, a swollen belly, or unexplained severe weakness needs an emergency vet immediately, not in the morning (Cornell University, 2024). Phone ahead and go. A bleeding spleen is one of the few cancers where the next hour genuinely matters. Our piece on cancer treatment emergencies covers the call-now signs in full.

Here's something that surprises a lot of owners, and it's worth knowing because it shapes how fast everything moves. With a bleeding splenic mass, the surgery often happens before anyone can tell you for certain that it's cancer.

When a dog arrives collapsed and bleeding internally, the vet's first job is to stabilise him, and then, if there's a mass on the spleen that's actively bleeding, the operation to remove the spleen (a splenectomy) is frequently the only thing that will stop the bleed and save his life that day. The trouble is that there's no way to be sure beforehand whether the mass is haemangiosarcoma or one of the more hopeful possibilities, and waiting for a definitive answer isn't an option while a dog is bleeding out.

This is the genuinely cruel bit, so it's worth saying plainly. Not every bleeding splenic mass is cancer. A meaningful proportion turn out to be benign, a blood blister or a non-cancerous growth, and those dogs can go on to do well after the spleen is removed. But a large share are haemangiosarcoma, and you usually only find out which one you're dealing with several days later, once the removed spleen has been examined under the microscope (Cornell University, 2024). So many families face the surgery decision in the worst possible circumstances, at speed, at night, not knowing whether they're paying for a cure or for a few more weeks. There's no good way to dress that up. If that's where you are, the only fair thing to say is that choosing the surgery to stop your dog bleeding and buy time to decide is a reasonable, loving choice, and so is deciding that an emergency operation isn't right for your dog. Neither is wrong.

You came here for honesty, so here it is, and please take it gently, with a cup of tea and someone beside you if you can.

For splenic haemangiosarcoma that has not obviously spread, surgery to remove the spleen on its own typically buys a median survival of only around two months, often quoted as roughly 1.6 months in the largest studies (Wendelburg et al., 2015; Cornell University, 2024). Adding chemotherapy after surgery, usually a drug called doxorubicin, extends that, to a median of around four to six months, but fewer than one in ten dogs are still alive a year after diagnosis (Cornell University, 2024). Without any treatment at all, once the cancer has declared itself with a bleed, many dogs have only days to a couple of weeks (AKC, 2023).

It's worth understanding why those numbers are so much shorter than for some other cancers. By the time a splenic tumour bleeds, it has very often already sent microscopic seeds elsewhere, most commonly to the liver, the lungs and the heart, even when scans look clear (Cornell University, 2024). The surgery removes the source, and chemotherapy slows the seeds, but neither reliably clears them, which is why this is a cancer we control briefly rather than cure.

A word too about what these figures are and aren't, because a median is widely misunderstood. The median is the midpoint, so half of dogs live longer than the number quoted, sometimes a good deal longer, and your dog is an individual, not a statistic. We explain how to read a survival figure properly, without being either crushed or falsely reassured, in our piece on reading a prognosis. But this is also the cancer where that candour cuts the other way, the one where we have to say clearly that the time really is short, so that you spend it well rather than chasing odds that mostly aren't there.

There's a sobering UK note worth adding, because the textbook figures come from specialist hospitals and don't always match real life. In a large study of dogs diagnosed with haemangiosarcoma in ordinary UK first-opinion practice, nearly half were put to sleep on the very day of diagnosis, and the overall median survival across the whole group was just nine days (Taylor et al., 2025). That isn't because UK vets give up. It's because so many dogs are only diagnosed at the point of a catastrophic bleed, when comfort, kindly and quickly given, is genuinely the most loving option on the table.

Not all haemangiosarcoma is the splenic nightmare, and it would be unfair to let you leave thinking it is. When the cancer arises in the skin, the picture can be far more hopeful, and it's worth knowing the difference exists.

There are really two skin versions, and they behave very differently. The first sits in the surface layer of the skin (the dermis) and is often caused by sun damage, so it tends to show up as a small red or purplish lump or patch on a thinly-haired, lightly-pigmented spot, the belly, the inner thigh, around the eyes, the kind of place that catches the sun (VSSO, 2024). This dermal, sun-related form is the good-news version. It spreads far less often, and for many dogs surgery alone is curative, with reported median survivals well over two years and sometimes far longer (VSSO, 2024). If your dog's haemangiosarcoma is one of these caught early, your outlook is genuinely different from everything above.

The second skin version sits deeper, under the skin in the fatty layer (the subcutaneous or hypodermal form), and this one behaves more like its internal cousin, with a higher chance of spreading and a more guarded outlook that depends heavily on how early it's caught (VSSO, 2024). So with a skin lump, the depth and the biopsy result matter enormously, and they're worth asking your vet about specifically. A small purple lump on a sun-exposed belly is a very different conversation from a deep one in the muscle.

Most cancer decisions in this space have a clear "more time" path and a clear "comfort" path, and time to weigh them. Haemangiosarcoma often robs you of the time, and that's perhaps the hardest thing about it. You may be deciding in an emergency room, exhausted and frightened, between a major operation with an uncertain payoff and saying goodbye. It's an awful position, and if you're in it, none of what follows is a test you can fail.

Broadly, the options are these. You can choose the surgery to stop the bleed and the chemotherapy that follows, accepting it as a way to buy good extra weeks to months rather than a cure, which suits families who want every reasonable bit of time and can manage the cost and the visits. You can choose the surgery alone, to stop a current bleed and have a little more time without the commitment of chemo. Or you can choose comfort care, deciding that an emergency operation and an uncertain few months aren't the right path for this dog, keeping him peaceful and pain-free, and letting him go kindly. We walk through that decision without any pressure either way in our piece on whether to treat, and through comfort-focused care as the active, loving choice it is.

What we'd gently steer you away from is the guilt, in either direction. Putting an older dog through major surgery for a short, uncertain gain is not selfish, and choosing not to is not giving up. The kindest measure here is not how long, but how good the time is, and you can track that with a quality-of-life score rather than leaving it to a frightened gut feeling. Whatever you choose, you have not let your dog down.

If the decision in front of you is the last one, please know you don't have to face the rest of it alone. Our piece on the quality-of-life decision is the gentlest place to go next, and from there our End-of-Life space holds everything else, the timing, the appointment itself, aftercare and grief, with the same care and none of the doom. Loving your dog all the way to the end, even when the end comes far too fast, is the whole of what matters.